First Time Loading...

OPKO Health Inc
NASDAQ:OPK

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
NASDAQ:OPK
Watchlist
Price: 1.23 USD -1.6%
Updated: Apr 25, 2024

Intrinsic Value

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. [ Read More ]

The intrinsic value of one OPK stock under the Base Case scenario is 1.91 USD. Compared to the current market price of 1.23 USD, OPKO Health Inc is Undervalued by 36%.

Key Points:
OPK Intrinsic Value
Base Case
1.91 USD
Undervaluation 36%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
OPKO Health Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling OPK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
OPKO Health Inc

Provide an overview of the primary business activities
of OPKO Health Inc.

What unique competitive advantages
does OPKO Health Inc hold over its rivals?

What risks and challenges
does OPKO Health Inc face in the near future?

Has there been any significant insider trading activity
in OPKO Health Inc recently?

Summarize the latest earnings call
of OPKO Health Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for OPKO Health Inc.

Provide P/S
for OPKO Health Inc.

Provide P/E
for OPKO Health Inc.

Provide P/OCF
for OPKO Health Inc.

Provide P/FCFE
for OPKO Health Inc.

Provide P/B
for OPKO Health Inc.

Provide EV/S
for OPKO Health Inc.

Provide EV/GP
for OPKO Health Inc.

Provide EV/EBITDA
for OPKO Health Inc.

Provide EV/EBIT
for OPKO Health Inc.

Provide EV/OCF
for OPKO Health Inc.

Provide EV/FCFF
for OPKO Health Inc.

Provide EV/IC
for OPKO Health Inc.

Show me price targets
for OPKO Health Inc made by professional analysts.

What are the Revenue projections
for OPKO Health Inc?

How accurate were the past Revenue estimates
for OPKO Health Inc?

What are the Net Income projections
for OPKO Health Inc?

How accurate were the past Net Income estimates
for OPKO Health Inc?

What are the EPS projections
for OPKO Health Inc?

How accurate were the past EPS estimates
for OPKO Health Inc?

What are the EBIT projections
for OPKO Health Inc?

How accurate were the past EBIT estimates
for OPKO Health Inc?

Compare the revenue forecasts
for OPKO Health Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of OPKO Health Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of OPKO Health Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of OPKO Health Inc compared to its peers.

Compare the P/E ratios
of OPKO Health Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing OPKO Health Inc with its peers.

Analyze the financial leverage
of OPKO Health Inc compared to its main competitors.

Show all profitability ratios
for OPKO Health Inc.

Provide ROE
for OPKO Health Inc.

Provide ROA
for OPKO Health Inc.

Provide ROIC
for OPKO Health Inc.

Provide ROCE
for OPKO Health Inc.

Provide Gross Margin
for OPKO Health Inc.

Provide Operating Margin
for OPKO Health Inc.

Provide Net Margin
for OPKO Health Inc.

Provide FCF Margin
for OPKO Health Inc.

Show all solvency ratios
for OPKO Health Inc.

Provide D/E Ratio
for OPKO Health Inc.

Provide D/A Ratio
for OPKO Health Inc.

Provide Interest Coverage Ratio
for OPKO Health Inc.

Provide Altman Z-Score Ratio
for OPKO Health Inc.

Provide Quick Ratio
for OPKO Health Inc.

Provide Current Ratio
for OPKO Health Inc.

Provide Cash Ratio
for OPKO Health Inc.

What is the historical Revenue growth
over the last 5 years for OPKO Health Inc?

What is the historical Net Income growth
over the last 5 years for OPKO Health Inc?

What is the current Free Cash Flow
of OPKO Health Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for OPKO Health Inc.

Financials

Balance Sheet Decomposition
OPKO Health Inc

Current Assets 309.5m
Cash & Short-Term Investments 95.9m
Receivables 130.2m
Other Current Assets 83.4m
Non-Current Assets 1.7B
Long-Term Investments 16.1m
PP&E 143.5m
Intangibles 1.5B
Other Non-Current Assets 9.1m
Current Liabilities 200.1m
Accounts Payable 69.7m
Accrued Liabilities 98.9m
Other Current Liabilities 31.5m
Non-Current Liabilities 422.4m
Long-Term Debt 229.3m
Other Non-Current Liabilities 193.1m
Efficiency

Earnings Waterfall
OPKO Health Inc

Revenue
863.5m USD
Cost of Revenue
-545.4m USD
Gross Profit
318.1m USD
Operating Expenses
-475.1m USD
Operating Income
-157m USD
Other Expenses
-31.8m USD
Net Income
-188.9m USD

Free Cash Flow Analysis
OPKO Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

OPK Profitability Score
Profitability Due Diligence

OPKO Health Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
Declining ROIC
26/100
Profitability
Score

OPKO Health Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

OPK Solvency Score
Solvency Due Diligence

OPKO Health Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
40/100
Solvency
Score

OPKO Health Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OPK Price Targets Summary
OPKO Health Inc

Wall Street analysts forecast OPK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPK is 4.34 USD with a low forecast of 1.52 USD and a high forecast of 8.93 USD.

Lowest
Price Target
1.52 USD
23% Upside
Average
Price Target
4.34 USD
252% Upside
Highest
Price Target
8.93 USD
626% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

OPK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

OPK Price
OPKO Health Inc

1M 1M
+22%
6M 6M
-3%
1Y 1Y
-10%
3Y 3Y
-72%
5Y 5Y
-48%
10Y 10Y
-85%
Annual Price Range
1.23
52w Low
0.8655
52w High
2.17
Price Metrics
Average Annual Return 21.79%
Standard Deviation of Annual Returns 113.29%
Max Drawdown -86%
Shares Statistics
Market Capitalization 857.3m USD
Shares Outstanding 696 990 000
Percentage of Shares Shorted 25.26%

OPK Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

OPKO Health Inc Logo
OPKO Health Inc

Country

United States of America

Industry

Biotechnology

Market Cap

857.3m USD

Dividend Yield

0%

Description

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 5,767 full-time employees. The Company’s segments include Diagnostics and Pharmaceutical. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP and hGH-CTP. The company also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.

Contact

FLORIDA
Miami
4400 Biscayne Blvd
+13055754181.0
http://www.opko.com/

IPO

1995-11-02

Employees

5 767

Officers

Chairman & CEO
Dr. Phillip Frost Ph.D.
Vice Chairman & Chief Technical Officer
Dr. Jane H. Hsiao M.B.A., Ph.D.
President & Vice Chairman
Dr. Elias Adam Zerhouni M.D.
Senior VP, CFO, Chief Accounting Officer & Treasurer
Mr. Adam E. Logal
Executive VP of Administration & Director
Mr. Steven D. Rubin Esq., J.D.
Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal
Dr. Akhtar Ashfaq FACP, FASN, M.D.
Show More
Chief Innovation Officer & Director
Dr. Gary J. Nabel M.D., Ph.D.
Chief Executive Officer of OPKO Renal
Dr. Charles W. Bishop
President of Transition Therapeutics
Dr. Antonio F. Cruz
President of OPKO Health Iberoamerica
Mr. Hans Berner
Show Less

See Also

Discover More
What is the Intrinsic Value of one OPK stock?

The intrinsic value of one OPK stock under the Base Case scenario is 1.91 USD.

Is OPK stock undervalued or overvalued?

Compared to the current market price of 1.23 USD, OPKO Health Inc is Undervalued by 36%.